FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: CGC

  • Home
  •  | 
  • Tag Archives: "CGC"

Canopy Growth acquires outstanding shares in BC Tweed Joint Venture

Canopy Growth acquires outstanding shares in BC Tweed Joint Venture
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to announce that it has closed its previously announced transaction (the "Transaction") to acquire the remaining 33% stake of BC Tweed Joint Venture Inc. ("BC Tweed").  The consolidation of the two largest federally licensed cannabis facilities in the world into full Canopy Growth ownership cements the Company's commitment to shareholder value through scale production.
Read more

Canopy Growth Completes Supply Agreement With the Manitoba Liquor and Lotteries Corporation

Canopy Growth Completes Supply Agreement With the Manitoba Liquor and Lotteries Corporation
Under the terms of the agreement, Canopy Growth will supply the Manitoba market with up to 6,500 kilograms of cannabis products over the next twelve months to meet demand from the adult use recreational cannabis market set to open on October 17, 2018. Manitobans can look forward to an industry-leading lineup of products from Tweed, the best-known cannabis brand in Canada, as well as partner brands including DNA Genetics and Leafs By Snoop.
Read more

Major Operational Milestones for Spectrum Cannabis in Europe: Plants and Product on the Move

Major Operational Milestones for Spectrum Cannabis in Europe: Plants and Product on the Move
With the successful transfer of live cannabis clones from Madrid-based partner, Alcaliber SA ("Alcaliber") to Spectrum Cannabis Denmark ApS ("Spectrum Cannabis Denmark"), the Company continues its expansion in Europe. Soon, export from Canada to Europe will be replaced with European GMP production. With legal frameworks in place in the major economies of Germany and Italy, the Company is applying its proven strategy of investing early in best-in-class GMP production platforms to offer patients and regulators a reliable source of medical cannabis close to home. 
Read more